<https://www.oneamyloidosisvoice.com/news-meeting/zentalis-pharmaceuticals-announces-first-patient-dosed-potentially-registrational-phase-1-2-bcl-2-inhibitor-zn-d5-relapsed-refractory-light-chain-amyloidosis/#webpage>
<http://schema.org/name>
"Zentalis Pharmaceuticals annonce le premier patient traité dans l'étude de phase 1/2 potentiellement d'enregistrement de l'inhibiteur de BCL-2 ZN-d5 | oneAmyloidosisvoice"
<https://fr.oneamyloidosisvoice.com/news-meeting/zentalis-pharmaceuticals-announces-first-patient-dosed-potentially-registrational-phase-1-2-bcl-2-inhibitor-zn-d5-relapsed-refractory-light-chain-amyloidosis/>